Gapping down
In reaction to news:
In reaction to news:
- EBIX -53.1% (reaches "stalking horse" sale agreement for life insurance and annuity business with Zinnia to ensure successful recapitalization efforts)
- PNT -11.1% (Eli Lilly and Company (LLY) extends the expiration of the tender offer to acquire all of the issued and outstanding shares of POINT Biopharma for $12.50 per share in cash to Dec 22 from Dec 15)
- SEIC -4.8% (increases share repurchase program by $250 mln increasing the available authorization under the program to ~$289 mln)
- TLSI -3.6% (files for 5,859,375 shares of common stock by selling shareholder)
- VFC -3.3% (detected unauthorized occurrences on a portion of its information technology)
- COIN -3.2% (asks court to review decision by SEC to deny cryptocurrency regulation petition, according to Reuters)
- DOOR -2.0% (announced a definitive agreement to acquire PGTI for a combination of cash and Masonite shares with a total transaction value of $3.0 bln)
- ORIC -1.5% (files for 12,142,852 shares of common stock by selling shareholders)
Analyst comments:
- AFRM -4.6% (downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt raised to $20)
- CUZ -4.0% (upgraded to Overweight from Neutral at JP Morgan; tgt raised to $27)
- BFH -3.2% (downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $36)
- HOUS -2.6% (downgraded to Underweight from Neutral at JP Morgan; tgt $7)
- ARM -1.6% (downgraded to Hold from Buy at Deutsche Bank; tgt raised to $70)
- MTB -1.2% (downgraded to Hold from Buy at Deutsche Bank; tgt $145)